▶주메뉴 바로가기
▶본문 바로가기
[THE INVESTOR] GC Medical Science said Sept. 12 it has broken ground for a plant that will manufacture hemodialysis solutions. Covering an area of 22,000 square meters in Eumseong, North Chungcheon...
[THE INVESTOR] Korea’s biotech firm SCM Lifescience said on Sept. 11 it has attracted 2 billion won (US$1.78 million) from the Yozma Group, an Israeli venture capital firm. With the investment, the...
[THE INVESTOR] ToolGen shares fell sharply on Sept. 11, wiping out over 224 billion won (US$198 million) from the company’s market cap over two days after news reports alleged that it stole patents ...
[THE INVESTOR] Hana Pharm said on Sept. 6 it plans to go public on the country’s main bourse next month to raise funds for facility investment to further advance its overseas market presence. It...
[THE INVESTOR] Celltrion Healthcare , the sales and marketing unit of biosimilar developer Celltrion, on Sept. 5 called on the UK’s public health service provider National Health Service to conside...
[THE INVESTOR] Alpha Holdings said in a regulatory filing on Sept. 3 that is seeking to enter the immune-oncology market by investing in NASDAQ-listed US firm OncoSec Medical. “Alpha Holdings has e...
[THE INVESTOR] Analysts are expecting Korean biotechnology and pharmaceutical stocks to gain momentum from this month with an upcoming international academic conference where the firms will present ...
[THE INVESTOR] Shrugging off concerns over overvaluation and uncertainties regarding accounting regulations, South Korea‘s pharmaceutical and bio companies have shown signs of regaining their presen...
[THE INVESTOR] L&C Bio, a tissue engineering company, said on Aug. 31 it has gained preliminary approval for its initial public offering on Korea‘s secondary bourse KOSDAQ. The company plans to flo...
[THE INVESTOR] Celltrion Healthcare , the marketing unit of biosimilar developer Celltrion , posted a 47 percent dip in first-half operating profit, hit by increased competition and lower selling...
[THE INVESTOR] Medytox said on Aug. 29 that it has filed a biologics license application with the Taiwan Food and Drug Administration for the sale of its botulinum toxin Neuronox. The news sent its ...
[THE INVESTOR] Celltrion said on Aug. 29 it has wrapped up phase 3 clinical trials for a subcutaneous formulation of its anti-inflammatory therapy Remsima, and will seek marketing approval in Europ...
[THE INVESTOR] Bukwang Pharmaceutical has secured over 80 billion won (US$72.13 million) through its investments in biotechnology companies. The investment return is 10 times bigger than its opera...
[THE INVESTOR] Daewoong Pharmaceutical Chairman Yoon Jae-seung said on Aug. 27 he will step down from all positions in the company following news reports of his abusive behavior against employees. ...
[THE INVESTOR ] Shares of JW Pharmaceutical rose over 5 percent on Aug. 27 as the Korean drug maker has signed a license agreement with Denmark-based LEO Pharma for its atopic dermatitis therapy i...
Hana Financial partners with SK Telecom and Kiwoom Securities for internet-only bank
CJ ENM denies Netmarble’s US$2b stake sell-off rumors
JW Life Science to giveW8b dividends
LG Innotek’s next cash cow: Time-of-flight module
Samsung’s cash reserves top W100tr
Kim Jong-un unlikely to tour Samsung’s Vietnamese smartphone factory: sources
LG all out to regain market share with upcoming G8, V50
LG CNS, AWS to accelerate corporate data migration to cloud
February 19, 2019
